Literature DB >> 2002658

Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue.

C E Bacchi1, A M Gown.   

Abstract

Villin is a 95-kilodalton gastrointestinal-related cytoskeletal protein associated with axial microfilament bundles of brush border microvilli. We tested the hypothesis that expression of this protein was restricted to adenocarcinomas of gastrointestinal origin in a retrospective study of 203 human neoplasm that had been fixed in Carnoy's or methacarn fixative and embedded in paraffin. Villin expression was restricted to a subset of epithelial tumors, with no expression noted in any cases of sarcoma, melanoma, or lymphoma. Villin proved to be a very sensitive and relatively specific marker of gastrointestinal adenocarcinomas: all colonic, gastric, and pancreatic carcinomas were positive, and none of the breast or lung carcinomas were positive, with the single exception of a bronchioalveolar adenocarcinoma. However, a subset of nongastrointestinal adenocarcinomas, including some adenocarcinomas of ovary, endometrium, and kidney, were also positive. Nonetheless, at least three distinct patterns of villin expression were discerned, some of which were quite specific for individual tumor types. Thus, an apical or brush border pattern of villin expression was seen in virtually all gastrointestinal adenocarcinomas, as well as in the occasional villin-positive endometrial or ovarian adenocarcinomas. A membranous distribution of carcinomas, mimicked the patterns of the normal counterpart tissue, e.g., delineation of bile canalicular structures. Finally, no relationship was found between the presence, or pattern of expression, of villin and the state of tumor differentiation. It is concluded that antibodies to villin may play an important role in immunocytochemical analyses of poorly differentiated malignant tumors in appropriately fixed, paraffin-embedded tissue and in cases where the primary site is indeterminant from clinical history and histology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002658

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Authors:  Maimaiti Xieraili; Mahmut Yasen; Kaoru Mogushi; Gulanbar Obulhasim; Abudureheman Mayinuer; Arihiro Aihara; Shinji Tanaka; Hiroshi Mizushima; Hiroshi Tanaka; Shigeki Arii
Journal:  Cancer Sci       Date:  2012-05-25       Impact factor: 6.716

Review 2.  Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Authors:  Koh Miura; Kazuyuki Ishida; Wataru Fujibuchi; Akihiro Ito; Hitoshi Niikura; Hitoshi Ogawa; Iwao Sasaki
Journal:  Surg Today       Date:  2012-03-23       Impact factor: 2.549

3.  Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.

Authors:  M T Kennedy; R C K Jordan; K W Berean; B Perez-Ordoñez
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

4.  Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin.

Authors:  F Terzi; R Maunoury; E Colucci-Guyon; C Babinet; P Federici; P Briand; G Friedlander
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.

Authors:  Chantell Wilson; Jieru E Lin; Peng Li; Adam E Snook; Jianping Gong; Takahiro Sato; Chengbao Liu; Melanie A Girondo; Hallgeir Rui; Terry Hyslop; Scott A Waldman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-10       Impact factor: 4.254

6.  Villin expression is frequently lost in poorly differentiated colon cancer.

Authors:  Diego Arango; Sheren Al-Obaidi; David S Williams; Higinio Dopeso; Rocco Mazzolini; Georgia Corner; Do-Sun Byun; Azadeh A Carr; Carmel Murone; Lars Tögel; Nikolajs Zeps; Lauri A Aaltonen; Barry Iacopetta; John M Mariadason
Journal:  Am J Pathol       Date:  2012-02-18       Impact factor: 4.307

Review 7.  Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).

Authors:  Taxiarchis Konstantinos Nikolouzakis; Loukia Vassilopoulou; Persefoni Fragkiadaki; Theodoros Mariolis Sapsakos; Georgios Z Papadakis; Demetrios A Spandidos; Aristides M Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2018-03-21       Impact factor: 4.136

8.  Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.

Authors:  Evamaria O Riedel; Arne Hinrichs; Elisabeth Kemter; Maik Dahlhoff; Mattias Backman; Birgit Rathkolb; Cornelia Prehn; Jerzy Adamski; Simone Renner; Andreas Blutke; Martin Hrabĕ de Angelis; Martin Bidlingmaier; Jochen Schopohl; Georg J Arnold; Thomas Fröhlich; Eckhard Wolf
Journal:  Mol Metab       Date:  2020-03-18       Impact factor: 7.422

9.  Loss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survival.

Authors:  Jaudah Al-Maghrabi; Wafaey Gomaa; Abdelbaset Buhmeida; Mohmmad Al-Qahtani; Mahmoud Al-Ahwal
Journal:  ISRN Gastroenterol       Date:  2013-09-05

10.  Regulation of intestinal epithelial cell cytoskeletal remodeling by cellular immunity following gut infection.

Authors:  S Solaymani-Mohammadi; S M Singer
Journal:  Mucosal Immunol       Date:  2012-08-22       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.